1-deoxynojirimycin has been researched along with Hepatitis B Virus Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Branza-Nichita, N; Durantel, D; Dwek, RA; Lazar, C; Macovei, A; Zitzmann, N; Zoulim, F | 1 |
1 other study(ies) available for 1-deoxynojirimycin and Hepatitis B Virus Infection
Article | Year |
---|---|
Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Topics: 1-Deoxynojirimycin; Cell Line; Endoplasmic Reticulum; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Glycosylation; Hepatitis B; Hepatitis B virus; Humans; Viral Envelope Proteins; Virulence; Virus Replication | 2007 |